Therapeutic targeting of acute lung injury and acute respiratory distress syndrome

Translational Research

Volumn 167, Issue 1, 2016, Pages 183-191

  Standiford, Theodore J ^a   Ward, Peter A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIOXIDANT; ASCORBIC ACID; COMPLEMENT; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; COMPLEMENT RECEPTOR; CORTICOSTEROID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPARIN; HISTONE; HYDROCORTISONE; INTERLEUKIN 18; INTERLEUKIN 1BETA; PROTEINASE; PROTEINASE INHIBITOR; SIVELESTAT; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; ANTIINFLAMMATORY AGENT;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; CAPILLARY ENDOTHELIUM; COMPLEMENT ACTIVATION; HUMAN; LUNG ALVEOLUS EPITHELIUM; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; ANIMAL; RESPIRATORY DISTRESS SYNDROME, ADULT;

ACUTE LUNG INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS; HUMANS; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84952638052     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2015.04.015     Document Type: Review

References (77)

1. L.B. Ware, and M.A. Matthay The acute respiratory distress syndrome N Engl J Med 342 2000 1334 1349
2. G.D. Rubenfeld, E. Caldwell, E. Peabody, and et al. Incidence and outcomes of acute lung injury N Engl J Med 353 2005 1685 1693
3. L.D. Hudson, and K.P. Steinberg Epidemiology of acute lung injury and ARDS Chest 116 1 suppl 1999 74S 82S
4. L.L. Dever, and W.G. Johanson Jr. Pneumonia complicating adult respiratory distress syndrome Clin Chest Med 16 1995 147 153
5. R.P. Marshall, G. Bellingan, S. Webb, and et al. Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome Am J Respir Crit Care Med 162 2000 1783 1788
6. M. Bachofen, and E.R. Weibel Structural alterations of lung parenchyma in the adult respiratory distress syndrome Clin Chest Med 3 1982 35 56
7. W.R. Anderson, and K. Thielen Correlative study of adult respiratory distress syndrome by light, scanning, and transmission electron microscopy Ultrastruct Pathol 16 1992 615 628
8. K.P. Steinberg, J.A. Milberg, T.R. Martin, R.J. Maunder, B.A. Cockrill, and L.D. Hudson Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome Am J Respir Crit Care Med 150 1994 113 122
9. E. Abraham Neutrophils and acute lung injury Crit Care Med 31 4 suppl 2003 S195 S199
10. W.L. Lee, and G.P. Downey Neutrophil activation and acute lung injury Curr Opin Crit Care 7 2001 1 7
11. S. Herold, M. Steinmueller, W. von Wulffen, and et al. Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand J Exp Med 205 2008 3065 3077
12. A.N. Chesnutt, M.A. Matthay, F.A. Tibayan, and J.G. Clark Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance Am J Respir Crit Care Med 156 3 Pt 1 1997 840 845
13. J.C. Horowitz, Z. Cui, T.A. Moore, and et al. Constitutive activation of prosurvival signaling in alveolar mesenchymal cells isolated from patients with nonresolving acute respiratory distress syndrome Am J Physiol Lung Cell Mol Physiol 290 2006 L415 L425
14. E. Abraham Coagulation abnormalities in acute lung injury and sepsis Am J Respir Cell Mol Biol 22 2000 401 404
15. S. Idell, K.K. James, E.G. Levin, and et al. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome J Clin Invest 84 1989 695 705
16. P. Prabhakaran, L.B. Ware, K.E. White, M.T. Cross, M.A. Matthay, and M.A. Olman Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury Am J Physiol Lung Cell Mol Physiol 285 2003 L20 L28
17. C. Martin, L. Papazian, M.J. Payan, P. Saux, and F. Gouin Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients Chest 107 1995 196 200
18. G. Matute-Bello, G. Downey, B.B. Moore, and et al. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals Am J Respir Cell Mol Biol 44 2011 725 738
19. G. Matute-Bello, C.W. Frevert, and T.R. Martin Animal models of acute lung injury Am J Physiol Lung Cell Mol Physiol 295 2008 L379 L399
20. J. Grommes, and O. Soehnlein Contribution of neutrophils to acute lung injury Mol Med 17 2011 293 307
21. G. Beilman Pathogenesis of oleic acid-induced lung injury in the rat: distribution of oleic acid during injury and early endothelial cell changes Lipids 30 1995 817 823
22. J.J. Osterholzer, P.J. Christensen, V. Lama, and et al. PAI-1 promotes the accumulation of exudate macrophages and worsens pulmonary fibrosis following type II alveolar epithelial cell injury J Pathol 228 2012 170 180
23. J.J. Osterholzer, M.A. Olszewski, B.J. Murdock, and et al. Implicating exudate macrophages and Ly-6C(high) monocytes in CCR2-dependent lung fibrosis following gene-targeted alveolar injury J Immunol 190 2013 3447 3457
24. D.W. Harkin, C.D. Marron, R.P. Rother, A. Romaschin, B.B. Rubin, and T.F. Lindsay C5 complement inhibition attenuates shock and acute lung injury in an experimental model of ruptured abdominal aortic aneurysm Br J Surg 92 2005 1227 1234
25. D.W. Harkin, A. Romaschin, S.M. Taylor, B.B. Rubin, and T.F. Lindsay Complement C5a receptor antagonist attenuates multiple organ injury in a model of ruptured abdominal aortic aneurysm J Vasc Surg 39 2004 196 206
26. A.B. Groeneveld, P.G. Raijmakers, J.A. Rauwerda, and C.E. Hack The inflammatory response to vascular surgery-associated ischaemia and reperfusion in man: effect on postoperative pulmonary function Eur J Vasc Endovasc Surg 14 1997 351 359
27. M. Bosmann, J.J. Grailer, K. Zhu, and et al. Anti-inflammatory effects of beta2 adrenergic receptor agonists in experimental acute lung injury FASEB J 26 2012 2137 2144
28. R.F. Guo, and P.A. Ward Role of oxidants in lung injury during sepsis Antioxid Redox Signal 9 2007 1991 2002
29. K. Newton, and V.M. Dixit Signaling in innate immunity and inflammation Cold Spring Harb Perspect Biol 4 2012 http://dx.doi.org/10.1101/cshperspect.a006049
30. Q. Zhang, M. Raoof, Y. Chen, and et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury Nature 464 2010 104 107
31. M. Bosmann, and P.A. Ward Role of C3, C5 and anaphylatoxin receptors in acute lung injury and in sepsis Adv Exp Med Biol 946 2012 147 159
32. M. Bosmann, J.J. Grailer, R. Ruemmler, and et al. Extracellular histones are essential effectors of C5aR- and C5L2-mediated tissue damage and inflammation in acute lung injury FASEB J 27 2013 5010 5021
33. F. Fattahi, J.J. Grailer, L. Jajou, F.S. Zetoune, A.V. Andjelkovic, and P.A. Ward Organ distribution of histones after intravenous infusion of FITC histones or after sepsis Immunol Res 61 2015 177 186
34. J. Tschopp, and K. Schroder NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 10 2010 210 215
35. R. Allam, M.N. Darisipudi, J. Tschopp, and H.J. Anders Histones trigger sterile inflammation by activating the NLRP3 inflammasome Eur J Immunol 43 2013 3336 3342
36. J.J. Grailer, B.A. Canning, M. Kalbitz, and et al. Critical role for the NLRP3 inflammasome during acute lung injury J Immunol 192 2014 5974 5983
37. J. Xu, X. Zhang, R. Pelayo, and et al. Extracellular histones are major mediators of death in sepsis Nat Med 15 2009 1318 1321
38. L. Liu, H. He, A. Liu, and et al. Therapeutic effects of bone marrow-derived mesenchymal stem cells in models of pulmonary and extrapulmonary acute lung injury Cell Transplant 2015 [Epub ahead of print]
39. A.E. Vaughan, A.N. Brumwell, Y. Xi, and et al. Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury Nature 517 2015 621 625
40. I.J. Laudes, J.C. Chu, S. Sikranth, and et al. Anti-C5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis Am J Pathol 160 2002 1867 1875
41. H.D. Jones, T.R. Crother, R.A. Gonzalez-Villalobos, and et al. The NLRP3 inflammasome is required for the development of hypoxemia in LPS/mechanical ventilation acute lung injury Am J Respir Cell Mol Biol 50 2014 270 280
42. S.M. Uriarte, M.J. Rane, M.L. Merchant, and et al. Inhibition of neutrophil exocytosis ameliorates acute lung injury in rats Shock 39 2013 286 292
43. K.C. Wildhagen, P. Garcia de Frutos, C.P. Reutelingsperger, and et al. Nonanticoagulant heparin prevents histone-mediated cytotoxicity in vitro and improves survival in sepsis Blood 123 2014 1098 1101
44. The identity problem Nat Biotechnol 28 2010 877
45. G.D. Kalliolias, and S.N. Liossis The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis Expert Opin Investig Drugs 17 2008 349 359
46. D. Liu, H.K. Lon, D.C. Dubois, R.R. Almon, and W.J. Jusko Population pharmacokinetic-pharmacodynamic-disease progression model for effects of anakinra in Lewis rats with collagen-induced arthritis J Pharmacokinet Pharmacodyn 38 2011 769 786
47. The Acute Respiratory Distress Syndrome Network Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network N Engl J Med 342 2000 1301 1308
48. J.M. Luce, A.B. Montgomery, J.D. Marks, J. Turner, C.A. Metz, and J.F. Murray Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock Am Rev Respir Dis 138 1988 62 68
49. K.P. Steinberg, L.D. Hudson, R.B. Goodman, and et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome N Engl J Med 354 2006 1671 1684
50. G.U. Meduri, E. Golden, A.X. Freire, and et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial Chest 131 2007 954 963
51. K. Iwata, A. Doi, G. Ohji, and et al. Effect of neutrophil elastase inhibitor (sivelestat sodium) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): a systematic review and meta-analysis Intern Med 49 2010 2423 2432
52. Y. Takano, H. Mitsuhashi, and K. Ueno 1alpha,25-Dihydroxyvitamin D(3) inhibits neutrophil recruitment in hamster model of acute lung injury Steroids 76 2011 1305 1309
53. D. Parekh, R.C. Dancer, S. Lax, and et al. Vitamin D to prevent acute lung injury following oesophagectomy (VINDALOO): study protocol for a randomised placebo controlled trial Trials 14 2013 100
54. B.J. Fisher, D. Kraskauskas, E.J. Martin, and et al. Attenuation of sepsis-induced organ injury in mice by vitamin C JPEN J Parenter Enteral Nutr 38 2014 825 839
55. L.B. Ware, and M.A. Matthay Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair Am J Physiol Lung Cell Mol Physiol 282 2002 L924 L940
56. H. Wu, T. Suzuki, B. Carey, B.C. Trapnell, and F.X. McCormack Keratinocyte growth factor augments pulmonary innate immunity through epithelium-driven, GM-CSF-dependent paracrine activation of alveolar macrophages J Biol Chem 286 2011 14932 14940
57. R. Paine 3rd, T.J. Standiford, R.E. Dechert, and et al. A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury Crit Care Med 40 2012 90 97
58. J.J. Presneill, T. Harris, A.G. Stewart, J.F. Cade, and J.W. Wilson A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction Am J Respir Crit Care Med 166 2002 138 143
59. A.J. Rosenbloom, P.K. Linden, A. Dorrance, N. Penkosky, M.H. Cohen-Melamed, and M.R. Pinsky Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients Chest 127 2005 2139 2150
60. H. Orozco, J. Arch, H. Medina-Franco, and et al. Molgramostim (GM-CSF) associated with antibiotic treatment in nontraumatic abdominal sepsis: a randomized, double-blind, placebo-controlled clinical trial Arch Surg 141 2006 150 153 discussion 4
61. C. Meisel, J.C. Schefold, R. Pschowski, and et al. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial Am J Respir Crit Care Med 180 2009 640 648
62. R.J. Mason, C.C. Leslie, K. McCormick-Shannon, and et al. Hepatocyte growth factor is a growth factor for rat alveolar type II cells Am J Respir Cell Mol Biol 11 1994 561 567
63. R.J. Mason, K. McCormick-Shannon, J.S. Rubin, T. Nakamura, and C.C. Leslie Hepatocyte growth factor is a mitogen for alveolar type II cells in rat lavage fluid Am J Physiol 271 1 Pt 1 1996 L46 L53
64. R.J. Panos, R. Patel, and P.M. Bak Intratracheal administration of hepatocyte growth factor/scatter factor stimulates rat alveolar type II cell proliferation in vivo Am J Respir Cell Mol Biol 15 1996 574 581
65. P. Singh-Kaw, R. Zarnegar, and J.M. Siegfried Stimulatory effects of hepatocyte growth factor on normal and neoplastic human bronchial epithelial cells Am J Physiol 268 6 Pt 1 1995 L1012 L1020
66. S. Idell Coagulation, fibrinolysis, and fibrin deposition in acute lung injury Crit Care Med 31 4 suppl 2003 S213 S220
67. B. Dixon, M.J. Schultz, R. Smith, J.B. Fink, J.D. Santamaria, and D.J. Campbell Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: a randomized controlled trial Crit Care 14 2010 R180
68. J.M. Erlich, D.S. Talmor, R. Cartin-Ceba, O. Gajic, and D.J. Kor Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study Chest 139 2011 289 295
69. A.A. Igonin, D.N. Protsenko, G.M. Galstyan, and et al. C1-esterase inhibitor infusion increases survival rates for patients with sepsis∗ Crit Care Med 40 2012 770 777
70. M.N. Islam, S.R. Das, M.T. Emin, and et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury Nat Med 18 2012 759 765
71. M.A. Matthay, A. Goolaerts, J.P. Howard, and J.W. Lee Mesenchymal stem cells for acute lung injury: preclinical evidence Crit Care Med 38 10 suppl 2010 S569 S573
72. J.W. Lee, A. Krasnodembskaya, D.H. McKenna, Y. Song, J. Abbott, and M.A. Matthay Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria Am J Respir Crit Care Med 187 2013 751 760
73. N. Gupta, X. Su, B. Popov, J.W. Lee, V. Serikov, and M.A. Matthay Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice J Immunol 179 2007 1855 1863
74. G. Zheng, L. Huang, H. Tong, and et al. Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study Respir Res 15 2014 39
75. J.G. Wilson, K.D. Liu, H. Zhuo, and et al. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial Lancet Respir Med 3 2015 24 32
76. K.D. Liu, J.G. Wilson, H. Zhuo, and et al. Design and implementation of the START (STem cells for ARDS treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome Ann Intensive Care 4 2014 22
77. M.D. Eisner, T. Thompson, L.D. Hudson, and et al. Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome Am J Respir Crit Care Med 164 2001 231 236